Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Brasschaat
Clinical trial register · Belgium

Clinical Trials in Brasschaat, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3055 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
3055
Studies in scope
all four open statuses
1723
Recruiting now
open to new participants
505
Lead sponsors
across recruiting studies
Top sites
Leuven 1275 Brussels 1118 Ghent 1030 Liège 562 Edegem 441
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca7 University Hospital, Antwerp6 Eli Lilly and Company6 Gilead Sciences5 AbbVie5 Pfizer4 Cancer Research Antwerp3 Novartis Pharmaceuticals3 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company3 Hoffmann-La Roche2 Celgene2 Bristol-Myers Squibb2 Janssen Research & Development, LLC2 MedSIR1 Stemline Therapeutics, Inc.1 Ascentage Pharma Group Inc.1 Merck Sharp & Dohme LLC1 Tesaro, Inc.1 Seagen, a wholly owned subsidiary of Pfizer1 BioNTech SE1 HUYABIO International, LLC.1 Australasian Gastro-Intestinal Trials Group1 General Hospital Groeninge1 Daiichi Sankyo1 Dafne Balemans1 Show all 35
Site location
Leuven1275 Brussels1118 Ghent1030 Liège562 Edegem441 Antwerp290 Bruges263 Roeselare249 Hasselt215 Aalst185 Kortrijk183 Charleroi175 Genk174 Anderlecht167 Yvoir153 Namur138 Jette128 Sint-Niklaas116 Bonheiden101 Wilrijk75 Brasschaat72 Mechelen61 La Louvière59 Woluwe-Saint-Lambert57 Ottignies48 Show all 205
All 205 locations
Target enrolment
to

Trials with a site in Brasschaat

72 of 3055 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Recruiting
Bristol-Myers Squibb
Phase 3
850
Anderlecht, Charleroi, Genk, Ghent, Sint-Niklaas, Leuven, Brasschaat
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Wilrijk, Auderghem, Leuven, Brasschaat
2026-03-12
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bonheiden, Brasschaat, Brussels, Genk, Hasselt, Ieper, Kluisbergen, Kortrijk
2025-12-01
Recruiting
The Belgian Society of Medical Oncology
Observational
550
Anderlecht, Antwerp, Bonheiden, Brasschaat, Edegem, Ghent, Gilly, Hasselt
2025-10-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Brasschaat, Genk, Sint-Niklaas, Liège
2025-10-08
Recruiting
Pfizer
Phase 3
680
Mechelen, Charleroi, Hasselt, Brasschaat
2025-09-29
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Aalst, Bonheiden, Brasschaat, Bruges, Brussels, Dendermonde, Erpent, Genk
2025-09-06
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Aalst, Alken, Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Edegem
2025-09-02
Recruiting
Pfizer
Phase 3
400
Brasschaat, Ottignies-Louvain-la-Neuve, Anderlecht, Brussels, Charleroi, Hasselt, Leuven, Kortrijk
2025-08-05
Recruiting
Pfizer
Phase 3
714
Mechelen, Brussels, Charleroi, Brasschaat, Liège
2025-07-23
Recruiting
MedSIR
Phase 2
200
Brasschaat, Ghent, Mons, Woluwe-Saint-Lambert
2025-06-30
Recruiting
AbbVie
Phase 2
110
Brasschaat, Brussels, Ghent, Leuven, Roeselare
2025-05-28
Recruiting
AbbVie
Observational
700
Brasschaat, Jette, Boussu, Charleroi, La Louvière, Liège, Genk, Sint-Niklaas
2025-03-28
Recruiting
Preoperative Radiation Therapy and Immediate Breast Reconstruction
NCT06739655Breast Neoplasms, Breast Carcinoma, Breast Adenocarcinoma, Cancer
Cancer Research Antwerp
Not applicable
180
Edegem, Wilrijk, Brasschaat, Namur, Ghent, Kortrijk
2025-02-20
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Aalst, Antwerp, Boussu, Brasschaat, Bruges, Brussels, Charleroi, Genk
2025-02-12
Recruiting
Alimentiv Inc.
Not applicable
378
Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Edegem, Ghent, Leuven
2025-02-01
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Antwerp, Brasschaat, Bruges, Ghent, Leuven, Roeselare
2025-01-22
Active, closed
AbbVie
Phase 2
185
Brasschaat, Leuven, Liège
2024-12-13
Recruiting
OSE Immunotherapeutics
Phase 3
363
Brasschaat, Leuven, Hasselt, Ghent, Namur, Kortrijk, Roeselare
2024-12-03
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Brasschaat, Ottignies, Aalst, Brussels, Charleroi, Hasselt, Sint-Niklaas, Leuven
2024-09-27
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Brasschaat, Herentals, Mechelen, Bruges, Roeselare, Antwerp
2024-09-16
Recruiting
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma
NCT06691425Non-metastasized Unresectable Pancreatic Carcinoma
Cancer Research Antwerp
Not applicable
160
Edegem, Wilrijk, Brasschaat, Bruges, Genk, Hasselt, Kortrijk, Roeselare
2024-07-19
By invitation
General Hospital Groeninge
Not applicable
339
Brasschaat, Edegem, Ghent, Leuven, Kortrijk, Bonheiden, Hasselt, Jette
2024-07-03
Active, closed
Remote MS Care in Antwerp
NCT06179758Multiple Sclerosis
University Hospital, Antwerp
Not applicable
100
Edegem, Antwerp, Brasschaat
2024-05-23
Active, closed
AbbVie
Phase 3
421
Brasschaat, Bruges
2024-05-19
Active, closed
Eli Lilly and Company
Phase 3
10,000
Aalst, Alken, Bonheiden, Brasschaat, Brussels, Edegem, Ghent, Hasselt
2024-04-30
Recruiting
Hoffmann-La Roche
Phase 4
320
Anderlecht, Brasschaat, Liège, Roeselare
2024-04-02
Active, closed
Eli Lilly and Company
Phase 3
17,300
Antwerp, Bonheiden, Brasschaat, Brussels, Charleroi, Dendermonde, Edegem, Genk
2024-03-05
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Brasschaat, Edegem, Ghent, Hasselt, Liège
2024-02-21
Active, closed
Genmab
Phase 3
1,095
Brasschaat, Edegem, Brussels, Liège, Ghent, Leuven, Roeselare
2024-02-05
Active, closed
AstraZeneca
Phase 3
1,902
Antwerp, Brasschaat, Charleroi, Ghent, Leuven, Libramont-Chevigny
2023-11-14
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Aalst, Auderghem, Bonheiden, Brasschaat, Bruges, Brussels, Haine-Saint-Paul, Hasselt
2023-10-24
Active, closed
AstraZeneca
Phase 3
5,511
Aalst, Anderlecht, Brasschaat, Brussels, Charleroi, Edegem, Ghent, Leuven
2023-10-05
Recruiting
University Hospital, Antwerp
Phase 4
270
Brasschaat, Rumst, Ghent, Sint-Niklaas, Leuven, Charleroi, Antwerp, Brussels
2023-06-28
Active, closed
Gilead Sciences
Phase 3
654
Antwerp, Brasschaat, Brussels, Leuven, Namur
2023-05-08
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Brasschaat, Haine-St-Paul, Kortrijk, Leuven, Liège
2023-03-29
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Roeselare, Brasschaat, Bruges
2023-02-03
Active, closed
Klus Pharma Inc.
Phase 2
240
Brasschaat, Charleroi, Woluwe-Saint-Lambert
2023-01-17
Recruiting
Gilead Sciences
Phase 3
1,514
Anderlecht, Brasschaat, Brussels, Gilly, Hasselt, Leuven, Liège, Roeselare
2022-12-12
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Antwerp, Brasschaat, Brussels, Ghent, Kortrijk, Libramont, Liège, Wuerzburg
2022-08-17
Active, closed
Gilead Sciences
Phase 3
443
Anderlecht, Brasschaat, Brussels, Charleroi, Ghent, Leuven, Namur
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Brasschaat, Brussels, Charleroi, Ghent, Leuven, Namur
2022-07-20
Recruiting
AbbVie
Phase 3
768
Brasschaat, Edegem, Charleroi, La Louvière, Hasselt, Ghent, Sint-Niklaas, Anderlecht
2022-03-25
Active, closed
AstraZeneca
Phase 3
1,035
Brasschaat, Ghent, Liège
2022-03-25
Active, closed
Eli Lilly and Company
Phase 3
368
Brasschaat, Hasselt, Namur
2022-03-11
Recruiting
Cancer Research Antwerp
Not applicable
128
Aalst, Brasschaat, Edegem, Genk, Hasselt, Kortrijk, Mechelen, Sint-Niklaas
2022-03-07
Recruiting
University Hospital, Antwerp
Observational
550
Rumst, Sint-Niklaas, Leuven, Antwerp, Brasschaat, Edegem
2022-01-03
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Genk, Yvoir, Kortrijk, Roeselare, Antwerp, Brasschaat, Bruges, Brussels
2021-11-23
Active, closed
Gilead Sciences
Phase 3
603
Brasschaat, Brussels, Edegem, Ghent, Mons
2021-11-17
Recruiting
University Hospital, Antwerp
Phase 3
150
Mechelen, Brasschaat, Edegem, Wilrijk, Charleroi, Ghent, Sint-Niklaas, Bruges
2021-08-16
Active, closed
HUYABIO International, LLC.
Phase 3
450
Brasschaat, Brussels, Ghent, Hasselt, Liège, Ottignies
2021-08-12
Active, closed
Dafne Balemans
Phase 4
736
Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Genk, Ghent, Lennik
2021-05-25
Active, closed
AstraZeneca
Phase 3
893
Brasschaat, Brussels, Edegem, Haine-Saint-Paul, Leuven
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 3
557
Brasschaat, Brussels, Leuven, Roeselare
2021-04-26
Active, closed
BioNTech SE
Phase 2
327
Bonheiden, Brasschaat, Charleroi, Kortrijk, La Louvière, Leuven, Roeselare, Wilrijk
2021-03-08
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Aalst, Bouge, Boussu, Brasschaat, Brussels, Ciney, Dendermonde, Edegem
2021-01-15
Active, closed
Daiichi Sankyo
Phase 3
1,600
Edegem, Ghent, Brasschaat, Brussels, Leuven, Liège, Wilrijk
2020-12-04
Active, closed
AstraZeneca
Phase 2
240
Brasschaat, Charleroi, Ghent, Haine-Saint-Paul, Leuven, Libramont-Chevigny, Namur
2020-04-22
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Brasschaat, Bruges, Ghent, Leuven
2019-08-12
Active, closed
Celgene
Phase 3
363
Antwerp, Brasschaat, Brussels, Charleroi, Kortrijk, Leuven, Roeselare
2019-01-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Brasschaat, Bruges, Brussels, Edegem, Ghent
2018-12-28
Recruiting
University Hospital, Antwerp
Not applicable
1,000
Brasschaat, Deurne, Edegem, Rumst, Sint-Niklaas, Antwerp
2018-11-05
Active, closed
Tesaro, Inc.
Phase 3
1,400
Brasschaat, Bruges
2018-10-11
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Brasschaat, Brussels, Ghent, Kortrijk, Roeselare, Tournai
2018-04-13
Active, closed
AstraZeneca
Phase 2
273
Brasschaat, Brussels, Charleroi, Leuven, Liège, Namur, Ottignies, Wilrijk
2018-03-07
Active, closed
ASPIRIN Trial Belgium
NCT03464305Colon Cancer
DrugAcetylsalicylic acid
University Hospital, Antwerp
Phase 3
148
Bornem, Brasschaat, Deurne, Edegem, Rumst, Sint-Niklaas, Antwerp, Bouge
2018-02-22
Active, closed
Pfizer
Phase 3
1,054
Brasschaat, Ghent, Kortrijk, Ottignies, Yvoir
2017-12-18
Active, closed
Eli Lilly and Company
Phase 3
5,637
Brasschaat, Edegem, Brussels, Lodelinsart, Hasselt, Liège, Libramont, Yvoir
2017-07-12
Active, closed
Geron Corporation
Phase 2/3
289
Antwerp, Wilrijk, Bruges, Kortrijk, Brasschaat, Ghent, Leuven
2016-01-12
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
Brasschaat, Edegem, La Louvière, Leuven, Ostend, Turnhout, Verviers
2009-09
Recruiting
The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders
NCT07021404Suicidal Ideation, Suicide Attempt, Multicenter Study, Epidemiological Study
University Hospital, Ghent
Observational
50,000
Aalst, Antwerp, Bilzen, Bonheiden, Brasschaat, Bruges, Deinze, Dendermonde
2006-12-31
Active, closed
AstraZeneca
Phase 3
736
Brasschaat, Brussels, Edegem, Ghent, Hasselt, Liège, Turnhout
2005-02-13
Rows per page Showing 1–72 of 72
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-belgium/city/brasschaat

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,055 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 72 of those studies with a site in Brasschaat.

How many clinical trials are recruiting in Brasschaat?

30 of the 72 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 41 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brasschaat), 72 studies
PhaseStudiesRecruitingShare
Phase 3431559.7%
Phase 29312.5%
Not applicable759.7%
Observational759.7%
Phase 2/3304.2%
Phase 4324.2%

Most active sponsors

Lead sponsors with the most studies (Brasschaat)
Lead sponsorStudiesRecruiting
AstraZeneca70
Eli Lilly and Company62
University Hospital, Antwerp64
AbbVie53
Gilead Sciences51
Pfizer43
Cancer Research Antwerp33
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company31
Novartis Pharmaceuticals30
Bristol-Myers Squibb22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.